Whilst J&J’s Shockwave has a strong grasp on the IVL market, other players are emerging with differentiated technologies.

The patients were assigned in a 1:1 ratio to either transcatheter mitral-valve repair and guideline-recommended medical therapy (device group) or medical therapy alone (control group). The three ...

Researchers found that transcatheter edge-to-edge repair is just as effective as surgery for patients with secondary mitral regurgitation and had a better safety profile.

Edwards launched its Sapien 3 transcatheter pulmonary valve implant (TPVI) system with Alterra adaptive prestent in Europe.

Few medical technologies have faced as many challenges and achieved as much success as transcatheter aortic valve ...

Results from the single-arm trial are the longest systematic follow-up to date, but experts are looking to the future.

Novel device-based therapies may overcome limitations of pharmacologic therapies for some patients living with heart failure (HF), indicating that a synergistic approach between the two therapies is ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Tricuspid transcatheter edge-to-edge repair (T-TEER ... or cardiac implantable electronic devices. It can cause fatigue and accumulation of fluid in the abdomen and lower limbs.

The RESHAPE-HF2 and MATTERHORN trials have specialists talking about whether the trials "open the door" for the treatment of ...